Neurology clinical trials recruiting in Illinois

103 recruiting neurology trials match in Illinois. Showing 20.

• A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseaseRecruiting

  Phase 3 · Hoffmann-La Roche · Chicago, Illinois

• Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's DementiaRecruiting

  N/A · Northwestern University · Chicago, Illinois

• Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS RegistryRecruiting

  N/A · Boston Scientific Corporation · Chicago, Illinois

• A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet SyndromeRecruiting

  Phase 1 / Phase 2 · Encoded Therapeutics · Chicago, Illinois

• A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseaseRecruiting

  Phase 3 · Hoffmann-La Roche · Chicago, Illinois

• A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)Recruiting

  Phase 3 · Merck Sharp & Dohme LLC · Chicago, Illinois

• Nomad P-KAFO StudyRecruiting

  N/A · Shirley Ryan AbilityLab · Chicago, Illinois

• A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's DiseaseRecruiting

  N/A · InSightec · Chicago, Illinois

• A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's DiseaseRecruiting

  Phase 2 / Phase 3 · Biohaven Therapeutics Ltd. · Chicago, Illinois

• A Study of AZD0120 in Autoimmune DiseasesRecruiting

  Phase 1 · AstraZeneca · Ann Arbor, Michigan

• Black and African Americans Connections to Parkinson's Disease (BLAAC PD)Recruiting

  N/A · Michael J. Fox Foundation for Parkinson's Research · Chicago, Illinois

• Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's DiseaseRecruiting

  Phase 3 · CereMark Pharma, LLC · Evanston, Illinois

• A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset EpilepsyRecruiting

  Phase 2 / Phase 3 · Biohaven Therapeutics Ltd. · Chicago, Illinois

• Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of MigrainesRecruiting

  Phase 3 · Wake Forest University Health Sciences · Oak Lawn, Illinois

• A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)Recruiting

  Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · Stuart, Florida

• Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual MigraineRecruiting

  Phase 3 · AbbVie · Tinley Park, Illinois

• rTMS to Improve Cognition in Parkinson'sRecruiting

  Phase 1 / Phase 2 · VA Office of Research and Development · Hines, Illinois

• A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseaseRecruiting

  Phase 4 · Impax Laboratories, LLC · Little Rock, Arkansas

• Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and ScootersRecruiting

  N/A · University of Illinois at Urbana-Champaign · Urbana, Illinois

• Longitudinal Early-onset Alzheimer's Disease Study ProtocolRecruiting

  N/A · Indiana University · Los Angeles, California

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.